barrons.com/public/page/9_0210-investorsentimentreadings.html Bullish stories: Discover [ DFS ; pg 14]; Diebold [ DBD ; pg 14]; ThermoFischer Scientific [ TMO ; pg 15]; USG [pg 16]; Synaptics [ SYNA ; pg 17; see link below]. SYNA story
discount narrowed to -8% . Cover Story “Barron’s 2014 Roundtable, Part III” . Panelists’ picks: Gabelli: JRN, DBD , CHMT, NFG, WFT, POST Rogers [Brian]: AMAT, CNX, CVC, ETR, NEM, PRMSX Hickey: CEF, AEM, GG, GDXJ, CCJ Black
investorsentimentreadings.html Bullish stories: Revlon [ REV ; takeover someday?; pg 19; see link below]; #2 ATM maker Diebold [ DBD ; yield 3.6%; new CEO; ATM upgrade cycle; pg 20]; midsize trucking outfit Con-way [ CNW ; ongoing restructuring and
We are no longer providing equity research on Diebold DBD . We provide broad coverage of more than 1,700 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.
We are placing Diebold DBD under review as we transfer coverage to a new analyst .
Diebold DBD is scheduled to release fiscal 2009 first-quarter results in a few weeks. We expect revenues in the ATM business to take a hit
Diebold DBD recently announced that the firm will let its existing poison pill expire on Feb. 11, 2009. We welcome this move by management
Untied Technologies UTX has withdrawn its offer to acquire Diebold DBD following Diebold management's rejection of the acquisition proposal. As a result, we are lowering our fair value estimate for Diebold to eliminate the premium implied in the acquisition offer.
improvements in internal controls. On the business operations side, Guidance's EnCase platform continues chalking up new customer wins, with Diebold DBD , Experian, and NATO among recent notable additions to the company's client roster.
Sunday, United Technologies UTX announced an unsolicited offer to acquire ATM maker and electronic security provider Diebold DBD for $2.6 billion, or $40 per share. The offer represents a 60% premium to Diebold's closing price Friday. We support